阿司匹林通过抑制花生四烯酸介导的小胶质细胞激活和神经炎症缓解雄性小鼠长期高脂饮食诱导的抑郁样行为
该研究在雄性小鼠中证实,长期(≥10周)高脂饮食暴露可诱导抑郁样行为,其机制涉及肠道菌群失调与多不饱和脂肪酸稳态破坏,尤其是促炎ω-6代谢物花生四烯酸(AA)升高。AA补充足以重现抑郁样行为并直接激活小胶质细胞NF-κB通路导致突触损伤。阿司匹林作为COX-1/COX-2双重抑制剂,可逆转高脂饮食诱导的行为缺陷,机制为直接抑制小胶质细胞过度激活并抑制AA及12-HETE等促炎ω-6衍生前列腺素合成。
要点
- 长期高脂饮食通过升高AA等ω-6促炎代谢物激活小胶质细胞并诱发抑郁样行为。
- AA补充 alone 足以重现抑郁样行为并直接引起小胶质细胞炎症激活和突触损伤。
- 阿司匹林通过抑制COX-1/COX-2及AA代谢通路逆转高脂饮食诱导的抑郁样行为。
核心结论
- AA是连接高脂饮食与神经炎症的关键病因学环节,阿司匹林靶向AA代谢通路可有效逆转高脂饮食诱导的抑郁样行为。
研究设计与样本
- 研究在雄性小鼠中进行,采用长期(≥10周)高脂饮食暴露模型,整合多组学和靶向脂质组学分析,并结合体内AA补充实验及体外神经元-小胶质细胞共培养实验。
主要发现
- 长期高脂饮食诱导小鼠出现抑郁样行为,伴随肠道菌群失调和多不饱和脂肪酸稳态破坏。
- 高脂饮食导致促炎ω-6代谢物(尤其AA)升高、抗炎ω-3代谢物降低,并与前额叶皮层和海马中小胶质细胞激活及IL-6、TNF-α、CCL2升高相关。
- AA补充 alone 足以在体内重现抑郁样行为,并在体外直接诱导小胶质细胞促炎激活、NF-κB通路上调和突触损伤。
- 阿司匹林治疗有效逆转高脂饮食诱导的行为缺陷,机制包括直接抑制小胶质细胞过度激活和抑制AA及12-HETE等促炎ω-6衍生前列腺素合成。
临床怎么用
- 提示监测长期高脂饮食人群的抑郁风险及ω-6/ω-3代谢状态可能具有临床意义。
- 阿司匹林靶向COX-1/COX-2及AA代谢通路或为代谢相关抑郁提供干预靶点,但需临床研究验证。
局限性
- 研究仅使用雄性小鼠,结论向雌性及人类外推需谨慎。
- 阿司匹林的疗效及安全性需在临床人群中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While Western dietary patterns are increasingly linked to neuropsychiatric disorders, the causal mechanisms by which chronic high-fat diet (HFD) contributes to depression remain elusive. Here, we demonstrate that prolonged ( ≥ 10 weeks) HFD exposure in mice robustly induces depressive-like behaviors, phenocopying chronic stress models. Integrating multi-omics and targeted lipidomics, we reveal that HFD-induced behavioral deficits are underpinned by gut microbiota dysbiosis and a profound disruption of polyunsaturated fatty acid (PUFA) homeostasis. This disruption is characterized by a surge in pro-inflammatory ω-6 metabolites, particularly arachidonic acid (AA), alongside a concomitant reduction in anti-inflammatory ω-3 metabolites. These lipid perturbations strongly correlate with marked microglial activation and elevated pro-inflammatory cytokine levels (IL-6, TNF-α, CCL2) in the prefrontal cortex and hippocampus. Functionally, AA supplementation alone was sufficient to recapitulate depressive-like behaviors in vivo and, through neuron-microglia co-culture assays, directly induce pro-inflammatory microglial activation, NF-κB pathway upregulation, and subsequent synaptic impairment in vitro. Critically, therapeutic intervention with aspirin, a dual COX-1/COX-2 inhibitor, effectively reversed HFD-induced behavioral deficits. This protection was mediated by a dual mechanism: directly inhibiting microglial hyperactivation and normalizing the neuroinflammatory milieu by suppressing the biosynthesis of pro-inflammatory ω-6-derived prostanoids, including AA and 12-HETE. Collectively, our findings identify AA as a critical etiological link between HFD and neuroinflammation, establishing a mechanistic framework for "metabolic depression." The profound therapeutic efficacy of aspirin validates the AA metabolic pathway, specifically COX-1/COX-2, as a promising and targetable node for intervention, offering translational insights for the burgeoning field of nutritional psychiatry.
引用
- Zhao B, Fan Y, Ma Q, et al. Aspirin alleviates long-term high-fat diet-induced depressive-like behavior in male mice via suppressing arachidonic acid-mediated microglial activation and neuroinflammation. Mol Psychiatry. 2026. PMID: 42457861. doi:10.1038/s41380-026-03752-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。